Directory Details

National Reference Laboratory (NRL) at ICAD Abu Dhabi

Initial Accreditation Date:Feb 19 , 2017

Contacts Info

Address

Abu Dhabi Business Hub | Unit C25/26 | ICAD 1 | P.O. Box 92323 Abu Dhabi | United Arab Emirates, Abu Dhabi, United Arab Emirates

PO box / Zip Code

92323

Email

fibrahim@nrl.ae

Website

www.nrl.ae

Phone No.

+971 04 444 4444

Main Field

Medical Laboratories

Valid Since:Jun 30 , 2026

Download Certificate

Type of Biological Sample	Components / Analytes	Examination Technique	Examination Procedure	Status
Haematology
EDTA Whole Blood	Sickle cell rapid test	Solubility	NRL-HE-OP-006	Voluntary withdrawal Since Jul 14, 2026
	ESR	Modified Westergren Manual technique	NRL-HE-SOP-005	Voluntary withdrawal Since Jul 14, 2026
	Hemoglobin A2	SEBIA/ Capillary electrphoresis	NRL-HEME-SOP-43	Voluntary withdrawal Since Jul 14, 2026
	Hgb fractionation		NRL-HEME-SOP-43	Voluntary withdrawal Since Jul 14, 2026
	Hgb fractionation with solubility		NRL-HEME-SOP-43	Voluntary withdrawal Since Jul 14, 2026
Immunology
Serum	C-Reactive Protein	Immunoturbidimetric	NRL-AC-SOP-125	Voluntary withdrawal Since Jul 14, 2026
	IgG Subclasses	Immunoturbidity	NRL-AC-SOP-121	Voluntary withdrawal Since Jul 14, 2026
	Free light chains	Immunoturbidity	NRL-AC-SOP-118	Voluntary withdrawal Since Jul 14, 2026
	Monoclonal IgGs	Immunofixation	NRL-AC-SOP-116	Voluntary withdrawal Since Jul 14, 2026
	Allergen specific IgE	FluorescentImmuno assay	NRL-IMM-SOP-055	Active
	ANA Screen	Multiplex Flow Immunoassay	NRL-IMM-SOP-003	Active
	Anti-Nuclear Antibodies	Immunofluoresence	NRL-MIC-SOP-78	Active
	Anti Deamidated Gliadin Abs IgA	Multiplexflow immunoassay	NRL-IMM-SOP-026	Active
	Anti Deamidated Gliadin Abs IgG		NRL-IMM-SOP-027	Active
	Anti Tissue Transglutaminase Abs IgA		NRL-IMM-SOP-024	Active
	Anti Tissue Transglutaminase Abs IgG		NRL-IMM-SOP-025	Active
	Anti Cardiolipin Antibodies IgG		NRL-IMM-SOP-029	Active
	Anti Cardiolipin Antibodies IgM		NRL-IMM-SOP-030	Active
	Anti Cardiolipin Antibodies IgA		NRL-IMM-SOP-028	Active
	Anti Beta-2-Glycoprotein-1 Abs IgA		NRL-IMM-SOP-031	Active
	Anti Beta-2-Glycoprotein-1 Abs, IgG		NRL-IMM-SOP-032	Active
	Anti Beta-2-Glycoprotein-1 Abs, IgM		NRL-IMM-SOP-033	Active
	Anti Glomerular Basement Membrane Abs		NRL-IMM-SOP-048	Active
	Anti MPO Antibodies		NRL-IMM-SOP-048	Active
	Anti Proteinase Antibodies	Multiplexflow immune assay	NRL-IMM-SOP-048	Active
	Anti TPO Antibodies	ECLIA	NRL-AC-SOP-076	Voluntary withdrawal Since Jul 14, 2026
	Anti TSH-Receptor Antibodies		NRL-AC-SOP-115	Voluntary withdrawal Since Jul 14, 2026
	Anti TG Antibodies		NRL-AC-SOP-075	Voluntary withdrawal Since Jul 14, 2026
Urine	Free light chains	Immunoturbidity	NRL-AC-SOP-118	Voluntary withdrawal Since Jul 14, 2026
	Immunoglobulin Free Light Chains, 24 hr Urine	Immunoturbidity	NRL-AC-SOP-118	Voluntary withdrawal Since Jul 14, 2026
	Monoklonal Igs	Immunofixation	NRL-AC-SOP-116	Voluntary withdrawal Since Jul 14, 2026
Serum	ALEX 2 Molecular Allergen Array	Enzyme-Linked Immunosorbent Assay		Active
Serum	ANCA (Anti-Neutrophil Cytoplasmic Antibodies)	Indirect Immunofluorescence Assay		Active
Molecular Pathology
Blood/ DNA	Common Hereditary Cancers Panel (47 Genes)	Next Generation Sequencing (NGS)	NRL-GNX-SOP-019/NRL-GNX-SOP-022 / NRL-GNX-SOP-023 / NRL-GNX-SOP-049/NRL-GNX-SOP-040/NRL-GNX-SOP-012	Active
	Hereditary Breast Cancer Panel (14 Genes)		NRL-GNX-SOP-019/NRL-GNX-SOP-022 / NRL-GNX-SOP-023 / NRL-GNX-SOP-049/NRL-GNX-SOP-040/NRL-GNX-SOP-012	Active
	Hereditary Breast and Ovarian Cancer Syndrome Panel (BRCA1 and BRCA2 Gene Sequencing)		NRL-GNX-SOP-019/NRL-GNX-SOP-022 / NRL-GNX-SOP-023 / NRL-GNX-SOP-049/NRL-GNX-SOP-040/NRL-GNX-SOP-012	Active
	Beta-Thalassemia (HBB Sequencing)	Sanger Sequencing	NRL-GNX-SOP-008/NRL-GNX-SOP-009/NRL-GNX-SOP-013/NRL-GNX-SOP-010/NRL-GNX-SOP-011/NRL-GNX-SOP-012	Active
	Beta-Thalassemia (HBB Deletion/Duplication)	Multiplex ligation- dependent probe amplification (MLPA)	NRL-GNX-SOP-015	Active
	Alpha- Thalassemia (HBA1 and HBA2 Sequencing)	Sanger Sequencing	NRL-GNX-SOP-007/NRL-GNX-SOP-009/NRL-GNX-SOP-013/NRL-GNX-SOP-010/NRL-GNX-SOP-011/NRL-GNX-SOP-012	Active
	Alpha- Thalassemia (HBA1 and HBA2 Deletion/Duplication)	Multiplex ligation- dependent probe amplification (MLPA)	NRL-GNX-SOP-014/NRL-GNX-SOP-009/NRL-GNX-SOP-013	Active
	BRCA1, BRCA2 Deletion Duplication Analysis	Multiplex ligation- dependent probe amplification (MLPA)	NRL-GNX-SOP-001. NRL- GNX-SOP-005. NRL-GNX- SOP-007. NRL-GNX-SOP- 008.NRL-GNX-SOP- 014NRL-GNX-SOP-015	Active
	Sickle Cell Disease Genetic Analysis	Sanger Sequencing	NRL-GNX-SOP-005. NRL- GNX-SOP-007.NRL-GNX- SOP-016	Active
	Known Familial Variant Analysis (One Exon, Sequencing)		NRL-GNX-SOP-013/NRL-GNX-SOP-010/NRL-GNX-SOP-011/NRL-GNX-SOP-012	Active
	Known Familial Variant Analysis (Two Exons, Sequencing)		NRL-GNX-SOP-013/NRL-GNX-SOP-010/NRL-GNX-SOP-011/NRL-GNX-SOP-012	Active
	Alpha and Beta Thalassemia Known Familial Variant Analysis		NRL-GNX-SOP-001. NRL- GNX-SOP-005. NRL-GNX- SOP-007. NRL-GNX-SOP- 008NRL-GNX-SOP-016	Active
Molecular Diagnostics
Whole Blood	BCR ABL1 p210, quant, blood	Real-time reverse transcription polymerase chain (RT-PCR)	NRL-GNX-SOP-029/NRL-GNX-SOP-030	Active
	BCR ABL1 p210, CML MRD, blood		NRL-GNX-SOP-052	Active
	JAK2 V617F, Quant, blood		NRL-GNX-SOP-037	Active
	JAK2 V617F, Qual, blood		NRL-GNX-SOP-037	Active
	BCR ABL1 p210 p190 p230, qual, blood		NRL-GNX-SOP-042	Active
Bone Marrow	BCR ABL1 p210, quant, marrow		NRL-GNX-SOP-029/NRL-GNX-SOP-030	Active
	JAK2 V617F, Quant, marrow		NRL-GNX-SOP-037	Active
	JAK2 V617F, Qual, marrow		NRL-GNX-SOP-037	Active
	BCR ABL1 p210 p190 p230, qual, marrow		NRL-GNX-SOP-042	Active
EDTA whole blood	Factor V Leiden Mutation (R506Q)	Real-time PCR	NRL-MDL-SOP-035 version 1.0_Thrombosis SNP detection by Real-time PCR	Active
	Factor II Mutation (G20210A)		NRL-MDL-SOP-035 version 1.0_Thrombosis SNP detection by Real-time PCR	Active
	MTHFR (C677T)		NRL-MDL-SOP-035 version 1.0_Thrombosis SNP detection by Real-time PCR	Active
EDTA Plasma	HIV 1 & HIV 2	Qualitative PCR	NRL-MDL-SOP-032 version 1.0_HIV-1/HIV-2 QuaLItative by Real -Time PCR	Active
Serum SST	HIV 1 & HIV 2	Qualitative PCR	NRL-MDL-SOP-032 version 1.0_HIV-1/HIV-2 Qualitative by Real -Time PCR	Active
Cervical Cells in ThinPrep/SurePath	HPV Genotype	Real-time PCR/Melting Curve	NRL-MDL-SOP-036 version 1.0_HPV Genotyping by Real-Time PCR	Active
Urine, UTM Swab	C.trachomatis & N.gonorrhoeaea		NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR	Active
	Herpes Simplex Virus 1&2		NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR	Active
	Trichomonas vaginalis		NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR	Active
	U.urealyticum & M.hominis		NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR	Active
	STI-11		NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR	Active
	Genital Infection		NRL-MDL-SOP-037 version 1.0_STI -11 and Genital Infection testing by Real-time PCR	Active
EDTA Plasma	HBV	Quantitative PCR	NRL-MDL-SOP-034 version 1.0_HBV Quantitative by Real -Time PCR	Active
EDTA Plasma	HCV	Quantitative PCR	NRL-MDL-SOP-033 version 1.0_HCV Quantitative by Real -Time PCR	Active
Molecular Genomics
Nasopharyngeal swab	Influenza A, Influnza B, RSV	Real-Time PCR	NRL-MDL-SOP-031 Detection of Influenza A, Influenza B, Respiratory Syncytial Virus ver.1.0	Active
Nasopharyngeal swab, Oropharyngeal swab, Sputum	Covid	Real-Time PCR	NRL-MDL-SOP-026 2019 Novel Coronavirus (COVID-19) ver.007	Active
Whole Blood	B Lymphoblastic Leukemia/Lymphoma Diagnosis (BCR-ABLp190quantitative), Blood	Real-time reverse transcription polymerase chain (RT-PCR)	NRL-GNX-SOP-061	Active
	B Lymphoblastic Leukemia/Lymphoma Diagnosis (BCR-ABLp190quantitative), Bone marrow	Real-time reverse transcription polymerase chain (RT-PCR)	NRL-GNX-SOP-061	Active
	Whole Exome Sequencing, proband only, blood	Next Generation Sequencing	NRL-GNX-SOP-057	Active
	Whole Exome Sequencing, Duo, blood		NRL-GNX-SOP-057	Active
	Whole Exome Sequencing, Trio, blood		NRL-GNX-SOP-057	Active
	Cardiomyopathy, NGS, blood		NRL-GNX-SOP-057	Active
	Familial Hypercholesterolemia, NGS, blood		NRL-GNX-SOP-057	Active
	Diabetes mellitus, monogenic, NGS, blood		NRL-GNX-SOP-057	Active
	Maturity onset diabetes of the young, MODY, NGS, blood		NRL-GNX-SOP-057	Active
	Retinitis Pigmentosa, NGS, blood		NRL-GNX-SOP-057	Active
	Albinism (NGS)		NRL-GNX-SOP-057	Active
	Arthrogryposis (NGS)		NRL-GNX-SOP-057	Active
	Lissencephaly (NGS)		NRL-GNX-SOP-057	Active
	Macrocephaly (NGS)		NRL-GNX-SOP-057	Active
	Microcephaly (NGS)		NRL-GNX-SOP-057	Active
	Leukodystrophy (NGS)		NRL-GNX-SOP-057	Active
	Neuronal Migration Disorder (NGS)		NRL-GNX-SOP-057	Active
	Joubert syndrome (NGS)		NRL-GNX-SOP-057	Active
	Craniosynostosis syndromes (NGS)		NRL-GNX-SOP-057	Active
	Microcephaly (PCNT)		NRL-GNX-SOP-057	Active
	Cardiomyopathy (NGS)		NRL-GNX-SOP-057	Active
	Cardiomyopathy, dilated (NGS)		NRL-GNX-SOP-057	Active
	Aortopathy (NGS)		NRL-GNX-SOP-057	Active
	Long QT syndrome (NGS)		NRL-GNX-SOP-057	Active
	Primary ciliary dyskinesia (NGS)		NRL-GNX-SOP-057	Active
	Kartagener syndrome (NGS)		NRL-GNX-SOP-057	Active
	Ataxic polyneuropathies (NGS)		NRL-GNX-SOP-057	Active
	Epilepsy (NGS)		NRL-GNX-SOP-057	Active
	Epilepsy, metabolic (NGS)		NRL-GNX-SOP-057	Active
	Cornelia de Lange syndrome (NGS)		NRL-GNX-SOP-057	Active
	Diabetes mellitus, permanent neonatal (NGS)		NRL-GNX-SOP-057	Active
	Diabetes mellitus, monogenic (NGS)		NRL-GNX-SOP-057	Active
	Obesity (NGS)		NRL-GNX-SOP-057	Active
	Maturity onset diabetes of the young (MODY) NGS		NRL-GNX-SOP-057	Active
	Dystonia (NGS)		NRL-GNX-SOP-057	Active
	Ectodermal dysplasia (NGS)		NRL-GNX-SOP-057	Active
	Autosomal dominant retinitis pigmentosa (NGS)		NRL-GNX-SOP-057	Active
	Autosomal recessive retinitis pigmentosa (NGS)		NRL-GNX-SOP-057	Active
	Bardet-Biedl syndrome (NGS)		NRL-GNX-SOP-057	Active
	Glaucoma (NGS)		NRL-GNX-SOP-057	Active
	Cone-rod dystrophy (NGS)		NRL-GNX-SOP-057	Active
	Retinitis Pigmentosa (NGS)		NRL-GNX-SOP-057	Active
	Familial hemophagocytic lymphohistiocytosis (NGS)		NRL-GNX-SOP-057	Active
	Autosomal dominant non-syndromic hearing loss (NGS)		NRL-GNX-SOP-057	Active
	Autosomal recessive non-syndromic hearing loss (NGS)		NRL-GNX-SOP-057	Active
	Prostate Cancer (NGS)		NRL-GNX-SOP-057	Active
	Spherocytosis, hereditary (NGS)		NRL-GNX-SOP-057	Active
	Ichthyosis and related disorders of cornification (NGS)		NRL-GNX-SOP-057	Active
	Ichthyosis, congenital (NGS)		NRL-GNX-SOP-057	Active
	Colorectal cancer, hereditary non-polyposis (NGS)		NRL-GNX-SOP-057	Active
	Congenital disorders of glycosylation (CDG) (NGS)		NRL-GNX-SOP-057	Active
	Disorders of sex development (DSD) (NGS)		NRL-GNX-SOP-057	Active
	Leigh syndrome (NGS)		NRL-GNX-SOP-057	Active
	Mitochondrial encephalopathy (NGS)		NRL-GNX-SOP-057	Active
	Lysosomal disorders (NGS)		NRL-GNX-SOP-057	Active
	Zellweger syndrome (NGS)		NRL-GNX-SOP-057	Active
	Familial Hypoglycemia (NGS)		NRL-GNX-SOP-057	Active
	Growth Hormone Deficiency (NGS)		NRL-GNX-SOP-057	Active
	CFTR Full Gene (NGS)		NRL-GNX-SOP-057	Active
	Nephrocalcinosis (NGS)		NRL-GNX-SOP-057	Active
	Nephronophthisis (NGS)		NRL-GNX-SOP-057	Active
	Hemolytic-uremic syndrome, atypical (NGS)		NRL-GNX-SOP-057	Active
	Nephrotic syndrome (NGS)		NRL-GNX-SOP-057	Active
	X-linked mental retardation (NGS)		NRL-GNX-SOP-057	Active
Autism (NGS)	NRL-GNX-SOP-057		Active
Limb-girdle muscular dystrophy (LGMD) (NGS)	NRL-GNX-SOP-057		Active
Spinal Muscular Atrophy, Distal (NGS)	NRL-GNX-SOP-057	Active
Muscular Dystrophies, Congenital (NGS)	NRL-GNX-SOP-057	Active
Myopathy, Distal (NGS)	NRL-GNX-SOP-057	Active
Charcot-Marie-Tooth disease (NGS)	NRL-GNX-SOP-057	Active
Spastic Paraplegia (NGS)	NRL-GNX-SOP-057	Active
Noonan/CFC/Costello (NGS)	NRL-GNX-SOP-057	Active
Parkinson Disease (NGS)	NRL-GNX-SOP-057	Active
Alzheimer (NGS)	NRL-GNX-SOP-057	Active
Periodic Fever Syndromes/Autoinflammation (NGS)	NRL-GNX-SOP-057	Active
3M syndrome (NGS)	NRL-GNX-SOP-057	Active
Osteogenesis imperfecta (NGS)	NRL-GNX-SOP-057	Active
Micromelic Dysplasia (NGS)	NRL-GNX-SOP-057	Active
Marfan syndrome (NGS)	NRL-GNX-SOP-057	Active
Ehlers-Danlos syndrome (NGS)	NRL-GNX-SOP-057	Active
Spondylometaphyseal Dysplasia and Spondyloepiphyseal Dysplasia (NGS)	NRL-GNX-SOP-057	Active
Waardenburg Syndrome (NGS)	NRL-GNX-SOP-057	Active
Warburg-Micro Syndrome (NGS)	NRL-GNX-SOP-057	Active
Wiskott-Aldrich syndrome (NGS)	NRL-GNX-SOP-057	Active
Carrier Screening (NGS) - Basic	NRL-GNX-SOP-057	Active
Carrier Screening (NGS) - Expanded	NRL-GNX-SOP-057	Active
GeneticHealthScreen (NGS)	NRL-GNX-SOP-057	Active
APOE genotyping, Alzheimer disease, blood	Real Time PCR	NRL-GNX-SOP-058	Active
JAK2 Exon 12 to 15, blood	Sanger Sequencing	NRL-GNX-SOP-031	Active
CALR Exon 9, blood		NRL-GNX-SOP-032	Active
MPL Exon 10, blood		NRL-GNX-SOP-033	Active
Acute Promyelocytic Leukemia (PML/RARA quantitative), Blood	Real-time reverse transcription polymerase chain (RT-PCR)	NRL-GNX-SOP-042	Active
MPN ( JAK2, CALR, MPL, JAK2 E12, Blood)	Real-time reverse transcription polymerase chain (RT-PCR) and Sanger Sequencing	NRL-GNX-SOP-052 /NRL-GNX-SOP-053/NRL-GNX-SOP-054/NRL-GNX-SOP-055	Active
BCRABL1p190, ALL MRD	Real-time reverse transcription polymerase chain (RT-PCR)	NRL-GNX-SOP-062	Active
Bone Marrow	JAK2 Exon 12 to 15, marrow	Sanger Sequencing	NRL-GNX-SOP-031	Active
	CALR Exon 9, marrow		NRL-GNX-SOP-032	Active
	MPL Exon 10, marrow		NRL-GNX-SOP-033	Active
	Acute Promyelocytic Leukemia (PML/RARA quantitative), Bone marrow	Real-time reverse transcription polymerase chain (RT-PCR)	NRL-GNX-SOP-042	Active
	MPN (JAK2, CALR, MPL, JAK2 E12, BM)	Real-time reverse transcription polymerase chain (RT-PCR) and Sanger Sequencing	NRL-GNX-SOP-052/NRL-GNX-SOP-054/NRL-GNX-SOP-055	Active
Amniotic Fluid	PND Whole Exome Sequencing, proband only, AF	Next Generation Sequencing	NRL-GNX-SOP-057	Active
Amniotic fluid, Whole Blood	PND Whole Exome Sequencing, Duo, AF		NRL-GNX-SOP-057	Active
Amniotic fluid, Whole Blood	PND Whole Exome Sequencing, Trio, AF		NRL-GNX-SOP-057	Active
Molecular Microbiology
Nasal Wsab/ RNA	SARS-CoV-2 Whole Genome Sequencing	TGS	NRL-GNX-SOP-026	Active
HLA & Transplant
ACD/ EDTA Whole Blood	HLA A,B,C,DRB1345,DQ,DP Low Resolution	PCR reverse sequence specific oligonucleotide probes (rSSOP) with Luminex® flow technology	NRL-HLA-SOP-003	Active
Serum	HLA Panel Reactive Antibody Screen	One Lambda LabMixed with Luminex® flow technology	NRL-HLA-SOP-005	Active
Serum	HLA Class I and II Antibody Identification	Solid Phase Single Antigen Bead (SAB) with Luminex® flow technology	NRL-HLA-SOP-006	Active
ACD/ EDTA Whole Blood & Serum	HLA Crossmatch	Flow Cytometry	NRL-HLA-SOP-012	Active
Whole Blood	HLA A,B,C,DRB1345,DQ,DP High Resolution NGS Typing Profile, Whole Blood	Long Read NGS		Active
Not applicable	HLA Virtual Crossmatch	In Silico donor specific antibody analysis		Active
Whole Blood	Rapid HLA A,B,C,DRB1345,DQ,DP Low Resolution Typing Profile, Whole Blood	RT-PCR with Hydrosis Probes		Active
Whole Blood		SSP RT-PCR		Active
NIPT
Whole Blood	Non Invasive Prenatal Screening (NGS) Basic without Fetal Sex	Next Generation Sequencing	NRL-GNX-NIPT-SOP-016, NRL-GNX-NIPT-SOP-024	Active
	Non Invasive Prenatal Screening (NGS) Basic with Fetal Sex		NRL-GNX-NIPT-SOP-016, NRL-GNX-NIPT-SOP-024	Active
	Non Invasive Prenatal Screening (NGS) Pro without Fetal Sex		NRL-GNX-NIPT-SOP-016, NRL-GNX-NIPT-SOP-024	Active
	Non Invasive Prenatal Screening (NGS) Pro with Fetal Sex		NRL-GNX-NIPT-SOP-016, NRL-GNX-NIPT-SOP-024	Active
Biochemistry
Serum	Fructosamine	Colorimetric	NRL-CHEM-SOP-069	Voluntary withdrawal Since Jul 14, 2026
	ACTH	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-001	Voluntary withdrawal Since Jul 14, 2026
	ALBUMIN	Colorimetric Assay (bromcresol green Complex )	NRL-CHEM-SOP-004	Voluntary withdrawal Since Jul 14, 2026
	ALKALINE PHOSPHATASE	Colorimetric	NRL-CHEM-SOP-013	Voluntary withdrawal Since Jul 14, 2026
	Alpha-1- antitrypsin	Turbidimetric	NRL-CHEM-SOP-040	Voluntary withdrawal Since Jul 14, 2026
	ALT	Kinetic (with pyridoxal-5'- phosphate)	NRL-CHEM-SOP-002	Voluntary withdrawal Since Jul 14, 2026
	AMYLASE	Enzymatic (Colorimetric)	NRL-CHEM-SOP-016	Voluntary withdrawal Since Jul 14, 2026
	Angiotensin Converting Enzyme	Kinetic	NRL-CHEM-SOP-018	Voluntary withdrawal Since Jul 14, 2026
	Anti-streptolysin O	Immunoturbidimetric	NRL-CHEM-SOP-024	Voluntary withdrawal Since Jul 14, 2026
	AST	Kinetic (rate of the NADH oxidation)	NRL-CHEM-SOP-028	Voluntary withdrawal Since Jul 14, 2026
	Beta HCG, Quant	Electrochemiluminescence Immunoassay	NRL-CHEM-SOP-029	Voluntary withdrawal Since Jul 14, 2026
	Bilirubin, direct	Colorimetric Diazo	NRL-CHEM-SOP-033	Voluntary withdrawal Since Jul 14, 2026
	Bilirubin, total	Colorimetric Diazo	NRL-CHEM-SOP-034	Voluntary withdrawal Since Jul 14, 2026
	Bilirubin, Total and Direct	Calculation	NA	Voluntary withdrawal Since Jul 14, 2026
	BUN (Urea)	Kinetic (Urease)	NRL-CHEM-SOP-145	Voluntary withdrawal Since Jul 14, 2026
	Calcium	Colorimetric (calcium-o- CPC complex)	NRL-CHEM-SOP-038	Voluntary withdrawal Since Jul 14, 2026
	Ceruloplasmin	Turbidimetric	NRL-CHEM-SOP-043	Voluntary withdrawal Since Jul 14, 2026
	Chloride	Ion-Selective Electrode (indirect)	NRL-CHEM-SOP-114	Voluntary withdrawal Since Jul 14, 2026
	Cholesterol	Kinetic (with oxidase)	NRL-CHEM-SOP-046	Voluntary withdrawal Since Jul 14, 2026
	CK	Enzymatic (Colorimetric)	NRL-CHEM-SOP-056	Voluntary withdrawal Since Jul 14, 2026
	CK-MB	Electrochemiluminescence Immunoassay	NRL-CHEM-SOP-047	Voluntary withdrawal Since Jul 14, 2026
	CO2 (Bicarbonate)	Enzymatic Colorimetric	NRL-CHEM-SOP-032	Voluntary withdrawal Since Jul 14, 2026
	Complement C3	Turbidimetric	NRL-CHEM-SOP-050	Voluntary withdrawal Since Jul 14, 2026
	Complement C4	Turbidimetric	NRL-CHEM-SOP-051	Voluntary withdrawal Since Jul 14, 2026
	Cortisol	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-053	Voluntary withdrawal Since Jul 14, 2026
	C-Peptide	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-036	Withdrawn Since Jul 14, 2026
	Creatinine	Enzymatic Colorimetric	NRL-CHEM-SOP-057	Withdrawn Since Jul 14, 2026
	DHEA-S	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-059	Withdrawn Since Jul 14, 2026
	Estradiol	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-164	Withdrawn Since Jul 14, 2026
	Ferritin	Immunoturbidimetric	NRL-CHEM-SOP-063	Withdrawn Since Jul 14, 2026
	Folate	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-064	Withdrawn Since Jul 14, 2026
	Free Thyroxine (FT4)		NRL-CHEM-SOP-068	Withdrawn Since Jul 14, 2026
	Free Triiodothyronine (FT3)		NRL-CHEM-SOP-067	Withdrawn Since Jul 14, 2026
	FSH		NRL-CHEM-SOP-065	Withdrawn Since Jul 14, 2026
	GGT	Enzymatic Colorimetric	NRL-CHEM-SOP-070	Withdrawn Since Jul 14, 2026
	Glucose	Enzymatic reference method with hexokinase	NRL-CHEM-SOP-073	Withdrawn Since Jul 14, 2026
	Growth Hormone	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-089	Withdrawn Since Jul 14, 2026
	HDL	Direct Enzymatic	NRL-CHEM-SOP-081	Withdrawn Since Jul 14, 2026
	Homocysteine	Turbidimetric	NRL-CHEM-SOP-086	Withdrawn Since Jul 14, 2026
	hsCRP	Immunoturbidimetric	NRL-CHEM-SOP-054	Withdrawn Since Jul 14, 2026
	Insulin	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-095	Withdrawn Since Jul 14, 2026
	Ionized Calcium	ISE (Direct)	NRL-AC-SOP-119	Withdrawn Since Jul 14, 2026
	Iron	Colorimetric (Transferrin‑Fe‑complex)	NRL-CHEM-SOP-098	Withdrawn Since Jul 14, 2026
	LDH	Enzymatic Colorimetri(L‑lactate to pyruvate)	NRL-CHEM-SOP-100	Withdrawn Since Jul 14, 2026
	LDL	Enzymatic	NRL-CHEM-SOP-101	Withdrawn Since Jul 14, 2026
	Lipase	Colorimetric	NRL-CHEM-SOP-103	Withdrawn Since Jul 14, 2026
	Luteinizing Hormone	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-106	Withdrawn Since Jul 14, 2026
	Magnesium	Colorimetric method (with Chlorophosphonazo)	NRL-CHEM-SOP-107	Withdrawn Since Jul 14, 2026
	Phosphorus	Colorimetric (phosphomolybdate formation) 1	NRL-CHEM-SOP-113	Withdrawn Since Jul 14, 2026
	Potassium	Ion-Selective Electrode (indirect)	NRL-CHEM-SOP-114	Withdrawn Since Jul 14, 2026
	ProBNP	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-108	Withdrawn Since Jul 14, 2026
	Progesterone		NRL-CHEM-SOP-116	Withdrawn Since Jul 14, 2026
	Prolactin		NRL-CHEM-SOP-117	Withdrawn Since Jul 14, 2026
	RF (Rheumatoid Factor)	Immunoturbidimetric	NRL-CHEM-SOP-123	Withdrawn Since Jul 14, 2026
	Sex Hormone Binding Globulin (SHBG)	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-127	Withdrawn Since Jul 14, 2026
	Sodium	Ion-Selective Electrode (indirect)	NRL-CHEM-SOP-114	Withdrawn Since Jul 14, 2026
	Testosterone	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-130	Withdrawn Since Jul 14, 2026
	Thyroid Stimulating Hormone (TSH)		NRL-CHEM-SOP-134	Withdrawn Since Jul 14, 2026
	Thyroxine (T4)		NRL-CHEM-SOP-135	Withdrawn Since Jul 14, 2026
	Total Bile Acids	Enzymatic colorimetric	NRL-CHEM-SOP-137	Withdrawn Since Jul 14, 2026
	TOTAL PROTEIN	Colorimetric-Biuret	NRL-CHEM-SOP-138	Withdrawn Since Jul 14, 2026
	Transferrin	Immunoturbidimetric	NRL-CHEM-SOP-141	Withdrawn Since Jul 14, 2026
	Triglyceride	Enzymatic (Trinder Endpoint Reaction)	NRL-CHEM-SOP-142	Withdrawn Since Jul 14, 2026
	Triiodothyronine (T3)	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-143	Withdrawn Since Jul 14, 2026
Unsaturated Iron Binding Capacity	Colorimetric	NRL-CHEM-SOP-161	Withdrawn Since Jul 14, 2026
Vitamin B12	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-149	Withdrawn Since Jul 14, 2026
Vitamin D 1,25 dihydroxy	Electrochemiluminescence immunoassay	NRL-AC-SOP-117	Withdrawn Since Jul 14, 2026
VLDL calculation only	Calculation	NRL-AC-SOP-011	Withdrawn Since Jul 14, 2026
Uric Acid	Enzymatic colorimetric (Uricase)	NRL-CHEM-SOP-146	Withdrawn Since Jul 14, 2026
Ethanol	Enzymatic Colorimetric	NRL-CHEM-SOP-062	Withdrawn Since Jul 14, 2026
IGF-1	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-096	Withdrawn Since Jul 14, 2026
Calcitonin	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-037	Withdrawn Since Jul 14, 2026
C-Reactive Protein	Immunoturbidimetric	NRL-CHEM-SOP-054	Withdrawn Since Jul 14, 2026
Anti-Mullerian Hormone (AMH)	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-019	Withdrawn Since Jul 14, 2026
Apolipoprotein B	Immunoturbidimetric	NRL-CHEM-SOP-027	Withdrawn Since Jul 14, 2026
Renin	Chemiluminescence	NRL-AC-SOP-129	Withdrawn Since Jul 14, 2026
Aldosterone	Chemiluminescence	NRL-AC-SOP-130	Withdrawn Since Jul 14, 2026
Carbohydrate Deficient Transferrin (CDT)	Capillary electrophoresis	NRL-AC-SOP-126	Withdrawn Since Jul 14, 2026
Serum Protein Electrophoresis	Capillary electrophoresis	NRL-AC-SOP-105	Withdrawn Since Jul 14, 2026
17-OH Progesterone	Chemiluminescent Immunoassay (CLIA)	NRL-IMM-SOP-084	Withdrawn Since Jul 14, 2026
Stool	Chemiluminescent Immunoassay (CLIA)	Faecal Pancreatic Elastase	NRL-IMM-SOP-082	Withdrawn Since Jul 14, 2026
Whole Blood	Tacrolimus	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-129	Withdrawn Since Jul 14, 2026
EDTA Whole Blood	RBC Folate	Electrochemiluminescence immunoassay	NRL-CHEM-SOP-064	Withdrawn Since Jul 14, 2026
CSF	GLUCOSE	Enzymatic (Hexokinase)	NRL-CHEM-SOP-073	Withdrawn Since Jul 14, 2026
	IgG	Immunoturbidimetric	NRL-CHEM-SOP-093	Withdrawn Since Jul 14, 2026
	Total Protein	Turbidimetric	NRL-CHEM-SOP-138	Withdrawn Since Jul 14, 2026
	Microalbumin	Immunoturbidimetric	NRL-CHEM-SOP-004	Withdrawn Since Jul 14, 2026
Urine	Creatinine	Enzymatic Colorimetric	NRL-CHEM-SOP-057	Withdrawn Since Jul 14, 2026
	Chloride	Ion-Selective Electrode (indirect)	NRL-CHEM-SOP-114	Withdrawn Since Jul 14, 2026
	Amylase	Enzymatic (Colorimetric)	NRL-CHEM-SOP-016	Withdrawn Since Jul 14, 2026
	Calcium	Colorimetric (calcium-o- CPC complex)	NRL-CHEM-SOP-038	Withdrawn Since Jul 14, 2026
	Glucose	Enzymatic reference method with hexokinase	NRL-CHEM-SOP-073	Withdrawn Since Jul 14, 2026
	Magnesium	Colorimetric method (with Chlorophosphonazo)	NRL-CHEM-SOP-107	Withdrawn Since Jul 14, 2026
	MicroAlbumin	Immunoturbidimetric	NRL-CHEM-SOP-004	Withdrawn Since Jul 14, 2026
	Phosphorous	Colorimetric (phosphomolybdate formation)	NRL-CHEM-SOP-113	Withdrawn Since Jul 14, 2026
	Potassium	Ion-Selective Electrode (indirect)	NRL-CHEM-SOP-114	Withdrawn Since Jul 14, 2026
	Sodium	Ion-Selective Electrode (indirect)	NRL-CHEM-SOP-114	Withdrawn Since Jul 14, 2026
	Urea	Kinetic (Urease)	NRL-CHEM-SOP-145	Withdrawn Since Jul 14, 2026
	Total Protein	Turbidimetric method with Benzethonium chloride	NRL-CHEM-SOP-138	Withdrawn Since Jul 14, 2026
	Uric acid	Enzymatic Colorimetric (Uricase)	NRL-CHEM-SOP-146	Withdrawn Since Jul 14, 2026
	Urine Ethanol	Enzymatic	NRL-CHEM-SOP-062	Withdrawn Since Jul 14, 2026
	Urine Drug Test - Qualitative	Immunoassay - (Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Marijuana, MDMA/XTC, Methadone, Methamphetamine, Morphine/ Opiate, Phencyclidine, Spice/K2c, Tramadol, Tricyclic Antidepressants) - Chromatographic Immuoassay (Alpha Scientific)	NRL-CM-SOP-010	Withdrawn Since Jul 14, 2026
	Urine Protein Electrophoresis	Capillary electrophoresis	NRL-AC-SOP-106	Active
CO2 of exhaled breath after intake of a substrate enriched with the stable isotope 13C	13C-Urea H. Pylori Breath Test	Isotope Mass Ratio Spectrophotometer IMRS	NRL-AC-SOP-122	Active
Faeces in extraction buffer tube	Faecal Immunochemical Test	Immunoassay	NRL-IMM-SOP-074	Active
Newborn Screening
Dried Blood Spot	G6PD	Fluorescence Immunoassay	NRL-NBS-SOP-005	Active
	Biotinidase		NRL-NBS-SOP-007	Active
	TSH		NRL-NBS-SOP-004	Active
	17OH Progesterone		NRL-NBS-SOP-008	Active
	GALT		NRL-NBS-SOP-003	Active
	Immuno Reactive Trypsinogen (IRT)		NRL-NBS-SOP-009	Active
	Hemoglobinopathies	High Performance Liquid Chromatography (HPLC)	NRL-NBS-SOP-022	Active
	Amino Acid	Flow injection Analysis Tandem Mass Spectrometry (LC/MS)	NRL-NBS-SOP-002	Active
	Acylcarnitine		NRL-NBS-SOP-002	Active
Plasma	Plasma Acylcarnitine		NRL-NBS-BCG-SOP-001	Active
Serum /Plasma	Methylmalonic Acid	LCMS/MS in negative ion	NRL-NBS-SOP-023	Active
Whole Blood	Vitamin B1	LCMS/MS in postive ion	NRL-NBS-SOP-024	Active
Whole Blood	Vitamin B6	LCMS/MS in postive ion	NRL-NBS-SOP-024	Active
Serology
Serum	HBsAb	Electrochemiluminescence immunoassay -Roche Cobas e601	NRL-IMM-SOP-020	Active
	HBsAg	Electrochemiluminescence immunoassay -Roche Cobas 8000 (e602)	NRL-IMM-SOP-017	Active
	HCV	Electrochemiluminescence immunoassay -Roche Cobas Pro	NRL-IMM-SOP-011	Active
	HBeAg	Electrochemiluminescence immunoassay -Roche Cobas e601	NRL-IMM-SOP-043	Withdrawn Since Jul 14, 2026
	HbeAb	Electrochemiluminescence immunoassay -Roche Cobas e601	NRL-IMM-SOP-044	Withdrawn Since Jul 14, 2026
	HIV Combi - HIV 1/2 Antibody & p24 Antigen	Electrochemiluminescence immunoassay -Roche Cobas 8000 (e602)	NRL-IMM-SOP-010	Active
	Toxoplasma IgG	Electrochemiluminescence immunoassay -Roche Cobas e601	NRL-IMM-SOP-004	Withdrawn Since Jul 14, 2026
	Toxoplasma IgM		NRL-IMM-SOP-005	Withdrawn Since Jul 14, 2026
	Rubella IgG		NRL-IMM-SOP-007	Active
	Rubella IgM		NRL-IMM-SOP-008	Active
	CMV IgG		NRL-IMM-SOP-006	Withdrawn Since Jul 14, 2026
	CMV IgM		NRL-IMM-SOP-023	Withdrawn Since Jul 14, 2026
	HSV-1IgG		NRL-IMM-SOP-021	Withdrawn Since Jul 14, 2026
	HSV-2IgG		NRL-IMM-SOP-022	Withdrawn Since Jul 14, 2026
	EBV,EarlyAntigenIgG	Multiplex Flow Immunoassay - BioRad Bioplex 2200	NRL-IMM-SOP-001	Active
	EBV,CapsidAntigenIgM		NRL-IMM-SOP-002	Active
	EBV,CapsidAntigenIgG		NRL-IMM-SOP-001	Active
	EBV,NuclearAntigenIgG		NRL-IMM-SOP-001	Active
	EBV,HeterophileAbsIgM		NRL-IMM-SOP-002	Active
	Varicella Zoster IgG	Chemiluminescent Immunoassay Diasorin XL	NRL-AC-SOP-091	Active
	Mycoplasma pneumoniae IgM	Chemiluminescent Immunoassay - Diasorin XL	NRL-IMM-SOP-036	Active
	Rapid Plasma Reagin (RPR), Qualitative	Flocculation	NRL-CM-SOP-008	Active
	Measles Antibodies, IgG	Chemiluminescent Immunoassay - Diasorin XL	NRL-IMM-SOP-066	Active
	Mumps Antibodies, IgG	Chemiluminescent Immunoassay - Diasorin XL	NRL-IMM-SOP-065	Active
	Brucella Antibodies, IgG	ELISA -Serion Immunomat	NRL-IMM-SOP-067	Active
	Brucella Antibodies, IgM	ELISA- Serion Immunomat	NRL-IMM-SOP-067	Active
	Helicobacter pylori Antibodies, IgA	ELISA -Serion Immunomat	NRL-IMM-SOP-068	Active
	Helicobacter pylori Antibodies, IgG	ELISA -Serion Immunomat	NRL-IMM-SOP-068	Active
	Helicobacter pylori Antibodies, IgM	ELISA- Serion Immunomat	NRL-IMM-SOP-068	Withdrawn Since Jul 14, 2026
	HIV 1 and 2 antibody confirmation	Lateral Flow Immunochromographic - BioRad Geenius	NRL-IMM-SOP-064	Active
	TB Feron	ELISA Standard E - Dynex DSX	NRL-IMM-SOP-081	Active
	Syphilis: Treponemal Antibodies	Chemiluminescent Immunoassay - COBAS 8000	NRL-IMM-SOP-083	Active
	Treponema pallidum Hemagglutination (TPHA)	Indirect hemaggutination	NRL-IMM-SOP-084	Active
	Rubella IgG	Electrochemiluminescence immunoassay -Roche Cobas Pro		Active
Microbiology
Stool	Organism isolation	Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)	NRL-MIC-SOP-02	Active
	H.PYLORI ANTIGEN	Rapid immunochromatographic test	NRL-MIC-SOP-80	Active
	Clostridium difficile toxin A& B		NRL-MIC-SOP-39	Active
	Rota/adenoviruses antigen		NRL-MIC-SOP-37	Active
	Modified Acid Fast Stain for CRYPTOSPORIDIUM,	Modified Acid fast Stain, Microscopy	NRL-MIC-SOP-50	Active
	pH Determination	pH strips visual colour change for numerical value	NRL-MIC-SOP-83	Active
Sputum, fasting gastric aspirate, induced sputum, tissue, biopsy, bronchial aspirate (washings/lavage) skin, cerebrospinal fluid (CSF), body fluid, stool, wound, abscess (except blood and bone marrow)	Acid Fast (Mycobacteria) Smear	Concentration by NAOH- NALC, Stain (Auramine and/or Kinyoun) and Microscopy	NRL-MIC-SOP-84	Active
Sputum, fasting gastric aspirate, induced sputum, tissue, biopsy, bronchial aspirate (washings/lavage), skin, cerebrospinal fluid (CSF), body fluid, stool, wound, abscess (except blood and bone marrow)	Acid Fast (Mycobacteria) isolation & Susceptibility- MGIT960; Identification of MPT64, (mycobacterial protein fraction secreted from MTbc cells)	Mycobacterial culture & sensitivity (MGIT™ 960 mycobacterial detection system); Rapid MGIT TBc identification test- chromatographic immunoassay,	NRL-MIC-SOP- 86,87,88,89	Active
Blood Culture	Organism isolation	BacT/ALERT® 3D Microbial Detection System	NRL-MIC-SOP-81	Active
Bacterial & Yeast growth on culture media	Organism ID by protein profiling	MALDI-TOF (Matrix Assisted Laser Desorption Ionization – Time of Flight) Mass Spectrometry	NRL-MIC-SOP-139	Active
Swab	Organism isolation	Conventional culture (if identification and/or	NRL-MIC-SOP-28	Active
Swab, sputum, tissue, fluids, blood culture, CSF, various specimens	Gram stain	Manual	NRL-MIC-SOP-06	Active
Vaginal swab/semen	Organism isolation	Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)	NRL-MIC-SOP-04	Active
Vaginal swab/semen	Organism (Gonococcous) isolation		NRL-MIC-SOP-04	Active
Sputum,Tracheal Aspirate & Bronchial lavage	Organism isolation		NRL-MIC-SOP-25	Active
Swab in transport medium	MRSA isolation	Conventional culture (MRSA Chrom agar ) & identification in MALDI TOF	NRL-MIC-SOP-26	Active
Throat swab	Organism isolation	Conventional culture+ then instrumentation is MALDI TOF	NRL-MIC-SOP-24	Active
Eye Swab		Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)	NRL-MIC-SOP-57	Active
Ear Swab			NRL-MIC-SOP-58	Active
Low vaginal swab, Rectovaginal swab, Vaginal secretions, Rectal swab	Group B streptococcus isolation	Conventional culture & identification in MALDI TOF	NRL-MIC-SOP-03	Active
Swab from skin, superficial	Organism isolation	Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)	NRL-MIC-SOP-59	Active
Female: vagina, cervix, Uterus, bartholingland secretions, clitoris			NRL-MIC-SOP-04	Active
Male: urethra, penis, prostate, epididymis & semenUrethral Culture			NRL-MIC-SOP-05	Active
Sputum, Tracheal Aspirate & Bronchial lavage			NRL-MIC-SOP-25	Active
Swab with Transport Medium	VRE isolation		NRL-MIC-SOP-60	Active
Faeces	Stool Analysis (Ova & Parasites, Colour, Consistency, WBC, RBC)	Stool (concentration and trichrome staining)	NRL-MIC-SOP-35	Active
Female Cervical swab, Male Urethral swab or Male Urine	Chlamydia Antigen	Rapid immunochromatographic test	NRL-MIC-SOP-61	Active
Nasal Wash, Nasopharyngeal Aspirate, Nasopharyngeal Swab and Nasal Swab	RSV Antigen	Rapid immunochromatographic test	NRL-MIC-SOP-77	Active
Wound swab, deep, Tissue, Fluid (not CSF)	Organism isolation	Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)	NRL-MIC-SOP-28	Active
Mouth, Nasal, Nasopharynx, & Sinuses (ethmoid, maxillary)	Organism isolation		NRL-MIC-SOP-23	Active
Swab,Urine, Sputum stool	Candida auris isolation	Conventional culture (Candida Chrom agar ) & identification in MALDI TOF	NRL-MIC-SOP-145	Active
Urine	Organism isolation	Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)	NRL-MIC-SOP-01	Active
Various Clinical samples	Fungus Culture	Culture		Active
Various Clinical samples	KOH Preparation	Microscopy		Active
Stool	Cryptosporidium and Giardia Antigen	Rapid immunoasay test		Active
Urine	Legionella Urinary Antigen			Active
Urine	Streptococcus pneumoniae Urinary Antigen			Active
Swab	ESBL Culture			Active
Serum/Plasma	Beta-D-Glucan	Lateral Flow Assay - Dry fluoresence immunoassay analyzer		Active
MGIT/LJ isolate	MOTT ID MALDI	MALDI-TOF - VITEK MS		Active
Fungus/Mold isolate	Fungus ID MALDI	MALDI-TOF - VITEK MS		Active
BAL	Nocardia culture	Conventional culture (if identification and/or sensitivity needed, then instrumentation is MALDI TOF and Vitek2 respectively)		Active
Clinical Pathology
Urine	Blood	Reflectance Spectrophotometer	NRL-HEME-SOP-33	Active
	WBC Esterase		NRL-HEME-SOP-33	Active
	Nitrites		NRL-HEME-SOP-33	Active
	Ketones		NRL-HEME-SOP-33	Active
	Glucose		NRL-HEME-SOP-33	Active
	Protein		NRL-HEME-SOP-33	Active
	Urobilinogen		NRL-HEME-SOP-33	Active
	Bilirubin		NRL-HEME-SOP-33	Active
	pH		NRL-HEME-SOP-33	Active
	Color		NRL-HEME-SOP-33	Active
	Specific Gravity		NRL-HEME-SOP-33	Active
	Appearance	Manual Microscopy	NRL-HEME-SOP-33	Active
	Others (bacteria/yeast)		NRL-HEME-SOP-33	Active
	WBC		NRL-HEME-SOP-33	Active
	RBC		NRL-HEME-SOP-33	Active
	Casts		NRL-HEME-SOP-33	Active
	Crystals		NRL-HEME-SOP-33	Active
	Epithelial Cells		NRL-HEME-SOP-33	Active
Genomics
EDTA blood, BM, blood smear	Myeloid Neoplasm, NGS, Varies	NGS		Active
	AML, 11 Genes, NGS, Varies			Active
	TP53 Full Gene Analysis, NGS, Varies			Active
	Myeloproliferative Neoplasm, NGS, Varies			Active
	Myelodysplastic Neoplasm, NGS, Varies			Active
	NPM1 Mutation Analysis, MRD, Blood			Active
EDTA Whole blood, AF, CVS	Custom Panel, NGS,Blood (1- 50 genes)			Active
EDTA Whole blood	Hereditary Hemochromatosis, DNA Analysis	RT-PCR		Active
EDTA Whole blood	Plasminogen activator inhibitor-1 (PAI-1) genotyping	RT-PCR		Active
FFPE	MSK-IMPACT Comprehensive Genomic Profiling, NGS, Varies	NGS		Active
	BRAF Somatic Mutation, Tumor	RT-PCR		Active
	KRAS Somatic Mutation, Tumor			Active
	EGFR Somatic Mutation, Tumor			Active
EDTA blood, BM	FLT3 Mutation Analysis, Blood	Fragment Analysis		Active
Molecular
ThinPrep, SurePath	HPV High Risk Genotype	Real Time PCR		Active
EDTA Plasma	CMV Quantitative,PCR,Plasma			Active
	EBV Quantitative,PCR,Plasma			Active
	BKV Quantitative, Varies			Active

Services	Approved Amount ()	Quantity	Amount ()
Accreditation Application
Document Review
Pre - Assessment Visit
Accreditation Assessment Visit
Follow Up Visit
Surveillance Visit
Extension in scope / Special Visit
Accreditation Certificate
Accreditation Symbols
Lifting of Suspension
Accreditation Re-Assessment Visit
Outside UAE (Fees apply)